Related Experiment Video
Updated: May 12, 2026

Chromatin Isolation by RNA Purification (ChIRP)
Published on: March 25, 2012
Directionality of noncoding human RNAs: how to avoid artifacts
Sivan Tzadok1, Yarden Caspin, Yafit Hachmo
1Department of Biochemistry and Molecular Biology, Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel.
Abstract:
Inactivation of tumor suppressor and metastasis suppressor genes via epigenetic silencing is a frequent event in human cancers. Recent work has shown new mechanisms of epigenetic silencing, based on the occurrence of long noncoding promoter-spanning antisense and/or sense RNAs (lncRNAs), which constitute part of chromatin silencing complexes. Using reverse transcription polymerase chain reaction (RT-PCR), we have started to scan "triple negative" and Her2-overexpressing breast cancer cell lines for directional/bidirectional transcription through promoters of tumor suppressor and metastasis suppressor genes known to be epigenetically silenced in vivo. Surprisingly, we found that RT-PCR-amplified products were obtained at high frequency in the absence of exogenous primers. These amplified products resulted from RT priming via transcripts originating from promoter or upstream spanning regions. Consequently, this priming overruled directionality determination and led to false detection-identification of such lncRNAs. We show that this prevalent "no primer" artifact can be eliminated by treating the RNA preparations with periodate, performing RT reactions at highly elevated temperatures, or a combination of both. These experimental improvements enabled determination of the presence and directionality of individual promoter-spanning long noncoding RNAs with certainty. Examples for the BRMS1 metastasis suppressor gene, as well as RAR-β2 and CST6 human tumor suppressor genes, in breast carcinoma cell lines are presented.
Insights
Researchers discovered a common artifact in detecting long noncoding RNAs (lncRNAs) that falsely identified their presence. New methods using periodate treatment and high-temperature reverse transcription (RT) accurately detect these cancer-related RNAs.
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Research
Background:
- Epigenetic silencing of tumor suppressor and metastasis suppressor genes is common in human cancers.
- Long noncoding RNAs (lncRNAs) are increasingly recognized as mediators of epigenetic silencing through chromatin modification.
- Detecting promoter-spanning lncRNAs is crucial for understanding cancer development.
Purpose of the Study:
- To investigate the presence and directionality of promoter-spanning lncRNAs in breast cancer cell lines.
- To identify and overcome a prevalent artifact in lncRNA detection using reverse transcription polymerase chain reaction (RT-PCR).
Main Methods:
- Screening of triple negative and Her2-overexpressing breast cancer cell lines for promoter-spanning transcripts.
- Utilizing RT-PCR to detect transcriptional activity.
- Implementing periodate treatment and high-temperature RT to eliminate a "no primer" artifact.
Main Results:
- A high frequency of RT-PCR products was observed without exogenous primers, indicating a "no primer" artifact.
- This artifact resulted from RT priming by promoter-associated transcripts, leading to false lncRNA identification.
- Periodate treatment and/or high-temperature RT effectively eliminated the artifact, enabling accurate lncRNA detection.
Conclusions:
- The study identifies and provides solutions for a significant artifact in lncRNA detection.
- Accurate identification of promoter-spanning lncRNAs, such as those associated with BRMS1, RAR-β2, and CST6, is now possible.
- These findings improve the reliability of studying lncRNAs involved in cancer epigenetics.
Related Concept Videos
Types of RNA
RNA Performs Diverse...
RNA Editing
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Leaky Scanning
RNA Stability
